| Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015 | 537 | 2015 |
| High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014 | 417 | 2014 |
| The placental gene PEG10 promotes progression of neuroendocrine prostate cancer S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ... Cell reports 12 (6), 922-936, 2015 | 283 | 2015 |
| Insulin receptor expression by human prostate cancers ME Cox, ME Gleave, M Zakikhani, RH Bell, E Piura, E Vickers, ... The Prostate 69 (1), 33-40, 2009 | 270 | 2009 |
| From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ... The Journal of pathology 227 (3), 286-297, 2012 | 219 | 2012 |
| Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model SL Krueckl, RA Sikes, NM Edlund, RH Bell, A Hurtado-Coll, L Fazli, ... Cancer research 64 (23), 8620-8629, 2004 | 217 | 2004 |
| Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression S Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ... European urology 73 (3), 322-339, 2018 | 202 | 2018 |
| A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy Z AbuGhosh, J Margolick, SL Goldenberg, SA Taylor, K Afshar, R Bell, ... The Journal of urology 189 (4), 1326-1331, 2013 | 148 | 2013 |
| Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum L Nappi, M Thi, A Lum, D Huntsman, BJ Eigl, C Martin, B O’Neil, ... Journal of clinical oncology 37 (33), 3090-3098, 2019 | 120 | 2019 |
| Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy S Taylor, J Margolick, Z Abughosh, SL Goldenberg, D Lange, WR Bowie, ... BJU international 111 (6), 946-953, 2013 | 118 | 2013 |
| BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11, 1-12, 2019 | 115 | 2019 |
| Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T—quantitative correlation with biopsy P Kozlowski, SD Chang, R Meng, B Mädler, R Bell, EC Jones, ... Magnetic resonance imaging 28 (5), 621-628, 2010 | 110 | 2010 |
| Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer Y Feng, VR Ramnarine, R Bell, S Volik, E Davicioni, VM Hayes, S Ren, ... BMC genomics 20, 1-8, 2019 | 109 | 2019 |
| Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ... Genome biology 15, 1-14, 2014 | 95 | 2014 |
| A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer SK Frees, J Aning, P Black, W Struss, R Bell, C Chavez-Munoz, M Gleave, ... World journal of urology 36, 215-220, 2018 | 92 | 2018 |
| Stromal gene expression is predictive for metastatic primary prostate cancer F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ... European urology 73 (4), 524-532, 2018 | 84 | 2018 |
| Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer C Wu, AW Wyatt, AV Lapuk, A McPherson, BJ McConeghy, RH Bell, ... The Journal of pathology 227 (1), 53-61, 2012 | 81 | 2012 |
| Targeting MCT 4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer SYC Choi, SL Ettinger, D Lin, H Xue, X Ci, N Nabavi, RH Bell, F Mo, ... Cancer medicine 7 (7), 3385-3392, 2018 | 74 | 2018 |
| Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles M Yu, D Zloty, B Cowan, J Shapiro, A Haegert, RH Bell, L Warshawski, ... Journal of investigative dermatology 128 (7), 1797-1805, 2008 | 72 | 2008 |
| SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA C Kockan, F Hach, I Sarrafi, RH Bell, B McConeghy, K Beja, A Haegert, ... Bioinformatics 33 (1), 26-34, 2017 | 67 | 2017 |
Colin Collins, PhDProfessor of Urologic Sciences, University of British Columbia and Vancouver Prostate CentreEmail được xác minh tại prostatecentre.com